Amphastar Pharmaceuticals
Stock Forecast, Prediction & Price Target
Amphastar Pharmaceuticals Financial Estimates
Amphastar Pharmaceuticals Revenue Estimates
Amphastar Pharmaceuticals EBITDA Estimates
Amphastar Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $437.76M N/A | $498.98M 13.98% | $644.39M 29.14% | Avg: $842.58M Low: $824.36M High: $863.63M avg. 30.75% | Avg: $936.66M Low: $847.92M High: $988.11M avg. 11.16% | Avg: $1.13B Low: $1.03B High: $1.20B avg. 21.62% | |
Net Income
% change YoY
| $62.11M N/A | $91.38M 47.12% | $137.54M 50.50% | Avg: $215.79M Low: $215.67M High: $251.75M avg. 56.89% | Avg: $253.14M Low: $257.91M High: $289.38M avg. 17.30% | Avg: $340.79M Low: $298.82M High: $365.13M avg. 34.62% | |
EBITDA
% change YoY
| $69.88M N/A | $107.49M 53.81% | $240.29M 123.53% | Avg: $131.60M Low: $128.76M High: $134.89M avg. -45.23% | Avg: $146.30M Low: $132.44M High: $154.33M avg. 11.16% | Avg: $177.93M Low: $161.08M High: $187.71M avg. 21.62% | |
EPS
% change YoY
| $1.3 N/A | $1.88 44.61% | $2.85 51.59% | Avg: $4.41 Low: $4.07 High: $4.75 avg. 54.72% | Avg: $5.16 Low: $4.87 High: $5.46 avg. 17.08% | Avg: $6.43 Low: $5.64 High: $6.89 avg. 24.53% | |
Operating Expenses
% change YoY
| $129.85M N/A | $141.36M 8.86% | $154.13M 9.03% | Avg: $134.42M Low: $131.51M High: $137.77M avg. -12.78% | Avg: $149.42M Low: $135.27M High: $157.63M avg. 11.16% | Avg: $181.74M Low: $164.52M High: $191.72M avg. 21.62% | |
FAQ
What is Amphastar Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 36.27% in 2025-2027.
We have gathered data from 4 analysts. Their low estimate is 215.67M, average is 215.79M and high is 251.75M.
What is Amphastar Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 21.18% in 2025-2027.
We have gathered data from 4 analysts. Their low revenue estimate is $824.36M, average is $842.58M and high is $863.63M.
What is Amphastar Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 32.11% in 2025-2027.
We have gathered data from 4 analysts. Their low earnings per share estimate is $4.07, average is $4.41 and high is $4.75.
What is the best performing analyst?
In the last twelve months analysts have been covering Amphastar Pharmaceuticals stock. The most successful analyst is David Amsellem whose win rate is 50%. He has correctly predicted 1/2 price targets.